ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Chiesi Farmaceutici S.p.A. clinical trials

Part of Valline S.r.l., which holds 76% as of 2026-05-13. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 299 studies whose lead sponsor is Chiesi Farmaceutici S.p.A. or one of 23 companies grouped under it. 37 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 24 registry names, not the registry’s. See them and correct one ↓

Compare Chiesi Farmaceutici with GlaxoSmithKline and Jiangsu HengRui Medicine →

Pipeline: 15 programs

Each counted once: 15 with a study Chiesi Farmaceutici S.p.A. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 6 with the most live studies.

Program
florensocatibPhase 3 · 3 live · Bronchiectasis · primary completion Dec 2026☆ Track
episalvanPhase 3 · 1 live · Amyotrophic Lateral Sclerosis☆ Track
birch triterpenesPhase 3 · 1 live · Epidermolysis Bullosa☆ Track
CHF5993 100/6/12.5 μg pMDI HFA-152aPhase 3 · 1 live · Asthma · primary completion Jun 2030☆ Track
Experimental: Participant Group CHF 5993 pMDI HFA-152aPhase 3 · 1 live · Asthma · primary completion Oct 2028☆ Track

1 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Chiesi Farmaceutici S.p.A.’s own registered studies; Chiesi Farmaceutici S.p.A.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Chiesi Farmaceutici S.p.A.’s studies test, most open studies first — 40 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 40; every drug is on its own page, and each page lists its sponsors.

Coming up

11 of Chiesi Farmaceutici S.p.A.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. 1F
  5. 1M
  6. A
  7. M
  8. 2J
  9. J
  10. 1A
  11. 1S
  12. 2O
  13. 1N

All 11

Show 6 more

Add all 11 to your calendar (.ics) → With an account.

All 299 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now3712%Recruiting 28 · Not yet recruiting 9
  • Completed22575%
  • Stopped early2910%Terminated 23 · Withdrawn 6
  • Status unknown or other83%Status unknown 3 · Available 2 · Approved for marketing 2 · No longer available 1

Phase

Where

  • United Kingdom91
  • United States82
  • Italy69
  • Germany55
  • Poland41
  • France36

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 2314
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 1226

By the year each study started; 22 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Chiesi Farmaceutici S.p.A.

  • Chiesi Farmaceutici S.p.A.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    185 studies
  • ApoPharma
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies →
  • Aegerion Pharmaceuticals, Inc.
    Acquired — became part of Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • KalVista Pharmaceuticals, Ltd.
    Acquired — became part of Chiesi Farmaceutici S.p.A., Jun 11, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    15 studies →
  • Zymenex A/S
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Birken AG
    Acquired — became part of Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Critical Therapeutics
    Acquired — became part of Chiesi Farmaceutici S.p.A., Jul 28, 2009 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Amryt Pharma
    Acquired — became part of Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Chiesi Italia
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Chiesi UK
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Chiesi Hungary Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Chiesi Poland Sp. z o.o.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Chiesi SAS
    Acquired — became part of Chiesi Farmaceutici S.p.A., Jul 28, 2009 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Chiasma, Inc.
    Acquired — became part of Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Atopix Therapeutics, Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Chiesi Canada Corp
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Cornerstone Therapeutics Inc.
    Acquired — became part of Chiesi Farmaceutici S.p.A., Jul 28, 2009 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Amryt Research Limited
    Acquired — became part of Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Chiesi Slovenija, d.o.o.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Chiesi Pharma AB, Nordic
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Chiesi Bulgaria
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Chiesi USA, Inc.
    Acquired — became part of Chiesi Farmaceutici S.p.A., Jul 28, 2009 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • EKR Therapeutics, Inc
    Acquired — became part of Chiesi Farmaceutici S.p.A., Jun 26, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Chiesi Farmaceutica Ltda.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Chiesi Farmaceutici S.p.A. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 299. Browse all 299 →